Monterey Bio Acquisition Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTRY research report →
Companywww.montereybio.com
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp.
- CEO
- Murat Omur
- IPO
- 2021
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $48.30M
- P/E
- -25.14
- P/S
- 0.00
- P/B
- 1.62
- EV/EBITDA
- -23.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1.86%
- ROIC
- -10.33%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,274,000 · -119.28%
- EPS
- $-0.44 · -989.11%
- Op Income
- $-2,039,000
- FCF YoY
- -6.85%
Performance & Tape
- 52W High
- $12.00
- 52W Low
- $10.21
- 50D MA
- $11.21
- 200D MA
- $11.03
- Beta
- 0.00
- Avg Volume
- 3.45K
Get TickerSpark's AI analysis on MTRY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 9, 23 | Chardan Monterey Investments LLC | buy | 478,125 |
| Mar 9, 23 | Chardan Monterey Investments LLC | sell | 13,125 |
| Sep 29, 22 | Chardan Monterey Investments LLC | other | 0 |
| Mar 9, 23 | GROSSMAN JONAS | buy | 478,125 |
| Mar 9, 23 | GROSSMAN JONAS | sell | 13,125 |
| Mar 9, 23 | NORTHSTAR BIO VENTURES, LLC | other | 75,000 |
| Mar 9, 23 | NORTHSTAR BIO VENTURES, LLC | sell | 570,000 |
| Mar 9, 23 | McKeever William | other | 0 |
| Mar 9, 23 | Satyal Sanjeev | other | 75,000 |
| Mar 9, 23 | Patel Sandip I | other | 75,000 |
Our MTRY Coverage
We haven't published any research on MTRY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTRY Report →